Avidity Biosciences Director Sells $3.8M in Stock
Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
- Latest
- Trending
Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
The Open Medical-LLM leaderboard offers valuable insights into AI-related medical devices, although none of the approved devices use generative AI.
GPT-4 shows promising potential in identifying stroke-affected brain regions, though it occasionally makes mistakes. Improving diagnosis speed could be beneficial, ...
Hungary is revolutionizing after-stroke care with an AI-based central decision support system. This groundbreaking system, funded by the EU, reduces ...
Assure Holdings announces merger agreement with Danam Health, creating a Nasdaq-listed entity in pharmaceutical and healthcare sectors. The merger is ...
The battle between humans and machines in gaming is explored, comparing the complexity of chess and Tetris. The emergence of ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.